Meloxicam

Chemical formula: C₁₄H₁₃N₃O₄S₂  Molecular mass: 351.401 g/mol  PubChem compound: 54677470

Therapeutic indications

Meloxicam is indicated for:

Rheumatoid arthritis

Population group: only adults (18 - 65 years old)

Rheumatoid arthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteoarthritis

Population group: only adults (18 - 65 years old)

Osteoarthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Rheumatoid arthritis

Population group: only elderly (65 years old or older)

Rheumatoid arthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ankylosing spondylitis

Population group: only adults (18 - 65 years old)

Ankylosing spondylitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Ankylosing spondylitis

Population group: only elderly (65 years old or older)

Ankylosing spondylitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteoarthritis

Population group: only elderly (65 years old or older)

Osteoarthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Meloxicam is contraindicated in the following cases:

Pregnancy

Pregnancy

Gastro-intestinal bleeding

Gastrointestinal hemorrhage

Peptic ulcer

Peptic ulcer

Bleeding

Bleeding

Severe heart failure

Heart failure New York Heart Assosiation Class IV

Perioperative pain after coronary artery bypass surgery (CABG)

Postoperative pain and additionally Repair of coronary artery

Severely impaired liver function

Hepatic failure stage IV

Non-dialysed severe renal failure

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Active intestinal inflammatory disease

Inflammatory disorder of digestive tract

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: MOBIC Tablet
Summary of Product Characteristics (SPC) 2017: MELOXICAM Orodispersible tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈